Assembly Biosciences, Inc.
ASMB
$36.10
$0.220.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.53% | 14.57% | 22.27% | 34.38% | 43.84% |
| Total Depreciation and Amortization | -28.73% | -50.76% | -63.69% | -71.33% | -63.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.44% | -29.80% | -66.45% | -87.76% | -84.38% |
| Change in Net Operating Assets | -132.45% | -128.27% | -124.01% | -115.65% | 996.62% |
| Cash from Operations | -343.00% | -329.52% | -302.08% | -324.76% | 132.69% |
| Capital Expenditure | 57.58% | 100.00% | 94.80% | 89.02% | 46.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -98.40% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -230.93% | 185.86% | 147.87% | 158.34% | -219.43% |
| Cash from Investing | -230.44% | 185.49% | 147.66% | 158.10% | -215.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 783.33% | -10.96% | 236.38% | 113.12% | 327.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 783.33% | -10.96% | 236.38% | 113.12% | 327.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -429.51% | 298.67% | 118.86% | 156.80% | 106.41% |